Evidence map›Paper›PMID 27510582›Full record

ArticleExperimental biology and medicine (Maywood, N.J.)2017

Original Research: Potential ocular protection and dynamic observation of Polygonatum sibiricum polysaccharide against streptozocin-induced diabetic rats' model.

Yi Wang, Shucun Qin, Guoqing Pen, Di Chen, Chao Han, Chunrun Miao, Baojin Lu, Chao Su, Shanlong Feng, Wen Li and 3 more

Open access · greenAbstract read
In one paragraph

Article in Experimental biology and medicine (Maywood, N.J.), 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
4.0field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 61 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Protective Effects ofToxics · 2025
    Article
  5. Antioxidants (Basel, Switzerland) · 2025
    Article
  6. Frontiers in nutrition · 2025
    Article
  7. Complementary efficacy and molecular insights ofFrontiers in endocrinology · 2025
    Review
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Advances in Mechanism Research onFrontiers in pharmacology · 2022
    Review
  16. Bioengineered · 2021
    Article
  17. Molecular medicine reports · 2021
    Article
  18. Article
  19. Antioxidant Effect ofBioMed research international · 2021
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 2 countries.

Yi WangDepartment of Ophthalmology, Chonbuk National University, Jeollabuk-do 561-756, Republic of Korea (past position).
Shucun QinKey Laboratory of Atherosclerosis in Universities of Shandong and Institute of Atherosclerosis, Taishan Medical University, Taian 271000, China.
Guoqing PenDepartment of Ophthalmology, Affiliated Hospital of Taishan Medical University, Taian 271000, China.
Di ChenDepartment of Ophthalmology, Affiliated Hospital of Taishan Medical University, Taian 271000, China.
Chao HanDepartment of Ophthalmology, Affiliated Hospital of Taishan Medical University, Taian 271000, China.
Chunrun MiaoDepartment of Ophthalmology, Affiliated Hospital of Taishan Medical University, Taian 271000, China.
Baojin LuDepartment of Ophthalmology, Affiliated Hospital of Taishan Medical University, Taian 271000, China.
Chao SuDepartment of Ophthalmology, Affiliated Hospital of Taishan Medical University, Taian 271000, China.
Shanlong FengDepartment of Ophthalmology, Affiliated Hospital of Taishan Medical University, Taian 271000, China.
Wen LiDepartment of Ophthalmology, Affiliated Hospital of Taishan Medical University, Taian 271000, China.
Jingjing HanDepartment of Ophthalmology, Affiliated Hospital of Taishan Medical University, Taian 271000, China.
Nam C ChoDepartment of Ophthalmology, Chonbuk National University, Jeollabuk-do 561-756, Republic of Korea (past position) cnauo@jbnu.ac.kr.
Yanhong SiKey Laboratory of Atherosclerosis in Universities of Shandong and Institute of Atherosclerosis, Taishan Medical University, Taian 271000, China zhaosixinkang@163.com.
Affiliated Hospital of Taishan Medical University · CNJeonbuk National University · KRTaishan Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Ocular complications associated with diabetes mellitus are progressive and becoming one of the most important causes of morbidity worldwide. The purpose of the study is to evaluate the protective effect of Polygonatum sibiricum polysaccharide, an important component of Polygonatum sibiricum, on ocular complications in streptozotocin-induced diabetes mellitus rats. Sprague Dawley rats were made diabetic with streptozotocin(60 mg/kg, i.v.) and then the rats were treated with Polygonatum sibiricum polysaccharide 200, 400 and 800 mg/kg.d by gavage for 12 weeks. Biochemical analysis indicated that Polygonatum sibiricum polysaccharide lowered the levels of fasting blood glucose and glycated hemoglobin in blood and elevated the levels of insulin and C-peptide in plasma of diabetes mellitus rats in a dose-dependent manner. Physical measurements revealed that Polygonatum sibiricum polysaccharide improved clinical symptoms of polydipsia, polyphagia, polyuria and weight loss in diabetes mellitus rats. The content of malondialdehyde and activity of superoxide dismutase in plasma were determined, and the data showed Polygonatum sibiricum polysaccharide suppressed oxidative stress reaction. Lens opacification was observed using slit lamp illumination, and the data showed Polygonatum sibiricum polysaccharide delayed cataract progression in a dose-dependent manner. Electroretinogram showed Polygonatum sibiricum polysaccharide treatment reversed the decrease of electroretinogram b and OPs2 waves' amplitudes. Flash-visual evoked potential test indicated that the peak time of P2 wave was prolonged, and the amplitude of N2-P2 was lowered in diabetes mellitus group, and Polygonatum sibiricum polysaccharide suppressed these changes. Fundus fluorescein angiography showed Polygonatum sibiricum polysaccharide alleviated the retinal vasculopathy in a dose-dependent manner. In conclusion, these results suggest that the administration of Polygonatum sibiricum polysaccharide slows the progression of diabetic retinopathy and cataract through alleviating hyperglycemia and reducing oxidative stress in streptozotocin-induced diabetes mellitus rats.

Indexed as

AnimalsCataractDiabetes Mellitus, ExperimentalDiabetic RetinopathyElectroretinographyEvoked Potentials, VisualGlucoseGlycated HemoglobinHypoglycemic AgentsMalePlants, MedicinalPolydipsiaPolygonatumPolysaccharidesPolyuriaRats, Sprague-DawleyGlucoseGlycated HemoglobinHypoglycemic AgentsPolysaccharidesStreptozocincataractdiabetes mellitusdiabetic retinopathyocular complicationsPolygonatum sibiricum polysaccharide

Identifiers

PMID27510582
PMCPMC5206980
OpenAlexW2504618822

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.